(Q44202173)

30 November 2017

title

Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? (English)

1 reference

30 November 2017

1 reference

Norman Jaffe

1

1 reference

30 November 2017

Humberto Carrasco

2

1 reference

30 November 2017

Kevin Raymond

3

1 reference

30 November 2017

Alberto Ayala

4

1 reference

30 November 2017

Farzin Eftekhari

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

95

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

2202-2210

1 reference

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

The metastatic patterns of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

Renal toxicity with cumulative doses of cis-diamminedichloroplatinum-II in pediatric patients with osteosarcoma. Effect on creatinine clearance and methotrexate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

Osteogenic sarcoma of the fourth thoracic vertebra. Long-term survival by chemotherapy only

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Control of primary osteosarcoma with chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Adjuvant chemotherapy in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10944

7 January 2021

Identifiers

DOI

10.1002/CNCR.10944

1 reference

30 November 2017

1 reference